Sarepta EVP Technical Ops resigns, Bilal Arif appointed as replacement

Sarepta Therapeutics, Inc.

William F. Ciambrone to resign as EVP Technical Operations effective Dec 31, 2022.
Ciambrone to consult through Q2 2023 at $500/hour; equity continues vesting.
Board appointed Bilal Arif as Chief Technical Operations Officer effective Dec 31, 2022.
Resignation not due to any disagreement with company operations or policies.
Ciambrone will receive 2022 annual bonus and COBRA coverage through consulting period.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Bilal Arif

Chief Technical Operations Officer

SRPT · Sarepta Therapeutics, Inc.

Effective: 2022-12-31
Filed: November 2, 2022, 7:59 PM ET

On October 31, 2022, the Board appointed Bilal Arif, the Company’s Senior Vice President, Strategy and Operations, as the Company’s Chief Technical Operations Officer, effective as of December 31, 2022 and upon Mr. Ciambrone’s retirement.

Departed

William F. Ciambrone

Executive Vice President, Technical Operations

SRPT · Sarepta Therapeutics, Inc.

Effective: 2022-12-31
Successor: Bilal Arif
Filed: November 2, 2022, 7:59 PM ET

On October 31, 2022, William F. Ciambrone informed Sarepta Therapeutics, Inc. (the “Company”) of his resignation from his position as the Company’s Executive Vice President, Technical Operations, effective as of December 31, 2022.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Bilal Arif was appointed as Chief Technical Operations Officer at Sarepta Therapeutics, Inc..

Action: appointed
Role: Chief Technical Operations Officer

Exact text from the filing

On October 31, 2022, the Board appointed Bilal Arif, the Company’s Senior Vice President, Strategy and Operations, as the Company’s Chief Technical Operations Officer, effective as of December 31, 2022 and upon Mr. Ciambrone’s retirement.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

William F. Ciambrone resigned as Executive Vice President, Technical Operations at Sarepta Therapeutics, Inc..

Action: resigned
Role: Executive Vice President, Technical Operations

Exact text from the filing

On October 31, 2022, William F. Ciambrone informed Sarepta Therapeutics, Inc. (the “Company”) of his resignation from his position as the Company’s Executive Vice President, Technical Operations, effective as of December 31, 2022.

View on SEC.gov

Sarepta Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-22-275897

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.